Form 4: Aura Biosciences' Chief Technology Officer Sells Shares to Cover Tax Obligations

Mark Plavsic, Chief Technology Officer of Aura Biosciences, sold 7,383 shares of common stock on October 16, 2024, at a price of $9.85 per share to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On October 16, 2024, Mark Plavsic, the Chief Technology Officer of Aura Biosciences, sold 7,383 shares of the company's common stock.
• The shares were sold at a price of $9.85 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Plavsic directly owns 121,132 shares of Aura Biosciences.
• A power of attorney was executed on the same date, granting Conor Kilroy and Amy Elazzouzi the authority to file reports on Forms 3, 4, and 5 on Plavsic's behalf regarding the ownership of Aura Biosciences securities.

Sentiment

Score: 6

Explanation: The document reflects a neutral event (stock sale for tax obligations) with no explicit positive or negative implications for the company's overall outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates